EFESA
LIVE

Serial Number

79391354

Owner

Genexine, Inc.

Attorney

Patricia A Wilczynski Brozek

Filing Date

Dec 22, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EFESA Trademark

Serial Number: 79391354 • Registration: 7709057

EFESA is a trademark filed by Genexine, Inc. on December 22, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Genexine, Inc. (16 trademarks)

(Magokdong, Bio Innovation Park) 172,

Entity Type: 98

Trademark Details

Filing Date

December 22, 2023

Registration Date

March 4, 2025

Published for Opposition

January 14, 2025

Goods & Services

Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment being pharmaceutical preparations for the treatment of dizziness; biological preparations for medical purposes being biological preparations for the treatment of anemia, kidney disease and kidney disorders; cardiovascular agents for medical purposes; drugs for medical purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; synthetic peptides for pharmaceutical purposes being synthetic peptides for the treatment of anemia, kidney disease and kidney disorders; pharmaceuticals being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; medicines for human purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; anemia treatment medicines that stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; medicines to stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; pharmaceutical preparations for treatment of chronic kidney disease and anemia; biological preparations for treatment of anemia; biological preparations to stimulate red blood cell production for veterinary and medical purposes being biological preparations for the treatment of anemia; synthetic peptides for pharmaceutical and anemia treatment purposes being synthetic peptides for the treatment of anemia; synthetic peptides for pharmaceutical and kidney disease treatment purposes being synthetic peptides for the treatment of kidney disease

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 19, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 19, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 29, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 13, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 13, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 5, 2025 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 4, 2025 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 4, 2025 NRCC
NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2025 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 19, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 22, 2024 GNFN
FINAL REFUSAL E-MAILED
Nov 22, 2024 GNFR
FINAL REFUSAL WRITTEN
Nov 22, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 12, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 25, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 8, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 8, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 24, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 23, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 23, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 22, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 14, 2024 REPR